Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

108
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
108
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K
Human Genetics01:28

Human Genetics

639
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
639
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

787
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
787
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

151
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
151
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Widespread white matter microstructural abnormalities in treatment‑naïve patients with first‑episode schizophrenia revealed by fixel-based analysis.

Translational psychiatry·2026
Same author

Schizophrenia and bipolar disorder: a comparative analysis of genetic and brain network connectivity.

Psychological medicine·2026
Same author

Age-Dependent Corpus Callosum Thickness Abnormalities and Clinical Implications in Treatment-Naïve First-Episode Schizophrenia.

Alpha psychiatry·2026
Same author

Individualized DTI-ALPS Identifies Phase-Specific Glymphatic Dysfunction in Early-Stage Bipolar Disorder.

Biomedicines·2026
Same author

Peripheral immune-redox signatures associate with cortical network alterations in anhedonic depression.

Molecular psychiatry·2026
Same author

Integrative Multi-Omics Mendelian Randomization Reveals Oxidative Stress Mechanisms in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia.

Antioxidants (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 1, 2025

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

Brain transcriptome-wide association study implicates novel risk genes underlying schizophrenia risk.

Chengcheng Zhang1, Xiaojing Li1, Liansheng Zhao1

  • 1Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

Psychological Medicine
|April 24, 2023
PubMed
Summary

This study identified eight novel schizophrenia (SCZ) risk genes by integrating gene expression and GWAS data. These genes are dysregulated in SCZ brains and linked to frontal-limbic dysfunction, suggesting potential therapeutic targets.

Keywords:
GWASTWASeQTLschizophreniawhite matter tract

More Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.5K

Related Experiment Videos

Last Updated: Aug 1, 2025

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.5K

Area of Science:

  • Neurogenetics
  • Psychiatric Genetics
  • Molecular Psychiatry

Background:

  • Schizophrenia (SCZ) is a complex psychiatric disorder with a significant genetic component.
  • Identifying specific risk genes and their regulatory mechanisms is crucial for understanding SCZ pathogenesis.
  • Previous studies have linked genetic risk variants to gene expression changes, but causal genes and mechanisms remain largely unknown.

Purpose of the Study:

  • To identify risk genes for schizophrenia (SCZ) regulated by known risk variants.
  • To explore the potential regulatory mechanisms underlying SCZ pathogenesis.
  • To investigate the association of novel SCZ risk genes with brain structure and function.

Main Methods:

  • Systematic integration of three independent brain expression quantitative trait loci (eQTL) datasets (CommonMind, GTEx, BrainSeq Phase 2) with genome-wide association study (GWAS) data.
  • Application of transcriptome-wide association study (TWAS) to identify genes associated with SCZ risk.
  • Utilized diffusion magnetic resonance imaging to assess white matter integrity and polygenic risk in SCZ patients.

Main Results:

  • Transcriptome-wide association study (TWAS) identified eight significant risk genes (CORO7, DDAH2, DDHD2, ELAC2, GLT8D1, PCDHA8, THOC7, TYW5) for SCZ.
  • These genes were confirmed by an independent integrative approach and found to be dysregulated in the dorsolateral prefrontal cortex of SCZ cases.
  • SCZ cases exhibited higher polygenic risk scores (PRS) for these genes, with cingulum-hippocampus fractional anisotropy mediating this effect.

Conclusions:

  • Identified novel SCZ risk genes, highlighting their importance in frontal-limbic dysfunctions.
  • The study provides insights into the molecular mechanisms of SCZ, implicating specific genes and neural pathways.
  • These findings suggest potential novel therapeutic targets for schizophrenia.